FN1 and lymphoma: In this study, two different tumor-bearing mouse models, e.g., the E.G7-OVA lymphoma model and the Lewis lung carcinoma model, were used to investigate the antitumor efficacy of an amino-rich FN nanoplatform loaded with different tumor antigens and immunostimulatory CpG ODNs.